Risk Analysis Stratification of CIN 2+ Development in a Cohort of Women Living with HIV with Negative Pap Smear and HR-HPV Test during a Long-Term Follow-Up.
Barbara GardellaAlberto AgarossiMattia DominoniIsabella PaganoSusanna Del FratiMaria Di GiminianiSelene CammarataChiara MelitoMarianna Francesca PasqualiLucia ZanchiValeria Maria SavasiArsenio SpinilloPublished in: Vaccines (2023)
WLWH with good immune status and negative Pap smear and HR-HPV test have a low risk for CIN2+.